## ANDRAS HECZEY

| | Title| Associate Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Pediatrics  
Address| 1102 BATES  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=Pq4z%2b2DeQIn2S8Ho5G4%3d&rnd=d27b83a1-0e64-4a15-92a5-5ff5a6790884)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=268789)  
  

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Biography  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
awards and honors

2015| Fellows' Excellence in Education Award, Texas Children's Cancer and
Hematology Centers  
---|---  
2012| TXCH Tumor Board Award, Baylor College of Medicine  
2009| Pediatric Associates and Affiliates Award, Children's Hospital of Los
Angeles  
2000| Good Student and Good Athlete of the Republic of Hungary , Ministry of
Education of Hungary  
2020| Young Investigator Award, Baylor College of Medicine  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Overview  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
overview

Dr. Andras Heczey is a physician-scientist and full-time faculty in the
Department of Pediatrics of Baylor College of Medicine, Section of Pediatric
Hematology and Oncology. He is a member of the multidisciplinary solid tumor
team and the Center for Cell and Gene Therapy (CAGT).  
  
His research focuses on developing novel treatments for children with solid
tumors by redirecting the immune system to attack cancer cells.  
  
Dr. Heczey has studied and published the first adoptive immunotherapy approach
utilizing Natural Killer T cells genetically modified to attack neuroblastoma,
he is working on moving this approach from bench-to-bedside in a form of a
Phase 1/2a clinical trial.  
  
As the Director of the Liver Tumor Program of Texas Children's Hospital, Dr.
Heczey has developed a strategy to target hepatoblastoma and hepatocellular
carcinoma with genetically engineered T lymphocytes and he is currently
evaluating this strategy in early Phase clinical trials in children and
adults.  
  
Dr. Heczey is a member of the Liver Tumor Program, the Neuroblastoma Program,
the Solid Tumor Team and the Center for Advanced Innate Cell Therapy.  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
keywords

  * [adoptive immunotherapy liver cancer neuroblastoma](https://profiles.viictr.org/search/default.aspx?searchtype=everything&searchfor=adoptive immunotherapy
liver cancer

neuroblastoma&exactphrase=false)

  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. [Arnett A](https://profiles.viictr.org/profile/34774547), Siegel DA, Dai S, Thompson TD, [Foster J](https://profiles.viictr.org/profile/1826370), di Pierro EJ, Momin B, [Lupo PJ](https://profiles.viictr.org/profile/270034), **Heczey A**. Incidence and survival of pediatric and adult hepatocellular carcinoma, United States, 2001-2020. Cancer Epidemiol. 2024 Jul 09; 92:102610. PMID: [38986355](//www.ncbi.nlm.nih.gov/pubmed/38986355).

Citations:  Fields:

Epi EpidemiologyNeo Neoplasms

  2. Miller A, Daum R, Wang T, Wu M, Tat C, Pfeiffer T, [Navai S](https://profiles.viictr.org/profile/6714386), **Heczey A** , [Hegde M](https://profiles.viictr.org/profile/270076), [Ahmed N](https://profiles.viictr.org/profile/268944), [Whittle SB](https://profiles.viictr.org/profile/3009971), Hill L, [Martinez C](https://profiles.viictr.org/profile/265827), [Krance R](https://profiles.viictr.org/profile/268199), [Ramos CA](https://profiles.viictr.org/profile/267038), [Rouce RH](https://profiles.viictr.org/profile/3010108), [Lulla P](https://profiles.viictr.org/profile/3010220), [Heslop HE](https://profiles.viictr.org/profile/269811), [Omer B](https://profiles.viictr.org/profile/3009902), Shekar M. Prolonged cytopenias after immune effector cell therapy and lymphodepletion in patients with leukemia, lymphoma and solid tumors. Cytotherapy. 2024 May 08. PMID: [38819365](//www.ncbi.nlm.nih.gov/pubmed/38819365).

Citations:  Fields:

Cel Cell BiologyThe Therapeutics

  3. Hu Y, Sarkar A, Song K, Michael S, Hook M, Wang R, **Heczey A** , Song X. Selective refueling of CAR T?cells using ADA1 and CD26 boosts antitumor immunity. Cell Rep Med. 2024 May 21; 5(5):101530. PMID: [38688275](//www.ncbi.nlm.nih.gov/pubmed/38688275); PMCID: [PMC11148642](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11148642).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/38688275/citedby/) Fields:

Med Medicine (General)

Translation:HumansAnimalsCells

  4. Che-Hsing L, Sharma S, **Heczey AA** , [Steffin DHM](https://profiles.viictr.org/profile/14348352), Louis CU, [Grilley BJ](https://profiles.viictr.org/profile/266987), Thakkar SG, Wu M, Wang T, [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811). Eighteen-year survival after GD2-directed Chimeric Antigen Receptor-Modified Immune Effector Cell Treatment for Neuroblastoma. Res Sq. 2024 Apr 11. PMID: [38659815](//www.ncbi.nlm.nih.gov/pubmed/38659815); PMCID: [PMC11042400](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11042400).

Citations:

  5. [Steffin D](https://profiles.viictr.org/profile/14348352), Ghatwai N, Montalbano A, Rathi P, [Courtney AN](https://profiles.viictr.org/profile/9596407), [Arnett AB](https://profiles.viictr.org/profile/34774547), Fleurence J, Sweidan R, Wang T, Zhang H, [Masand P](https://profiles.viictr.org/profile/269955), Maris JM, Martinez D, Pogoriler J, Varadarajan N, Thakkar SG, Lyon D, Lapteva N, [Mei Z](https://profiles.viictr.org/profile/267093), Patel K, [Lopez-Terrada D](https://profiles.viictr.org/profile/266283), [Ramos C](https://profiles.viictr.org/profile/267038), [Lulla P](https://profiles.viictr.org/profile/3010220), [Armaghany T](https://profiles.viictr.org/profile/28999477), [Grilley BJ](https://profiles.viictr.org/profile/266987), Dotti G, [Metelitsa LS](https://profiles.viictr.org/profile/266187), [Heslop HE](https://profiles.viictr.org/profile/269811), [Brenner MK](https://profiles.viictr.org/profile/268200), [Sumazin P](https://profiles.viictr.org/profile/2560346), **Heczey A**. Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers. Res Sq. 2024 Apr 03. PMID: [38645165](//www.ncbi.nlm.nih.gov/pubmed/38645165); PMCID: [PMC11030543](//www.ncbi.nlm.nih.gov/pmc/articles/PMC11030543).

Citations:

  6. **Heczey A** , Xu X, [Courtney AN](https://profiles.viictr.org/profile/9596407), [Tian G](https://profiles.viictr.org/profile/1826488), Barragan GA, Guo L, Amador CM, Ghatwai N, Rathi P, Wood MS, Li Y, Zhang C, Demberg T, Di Pierro EJ, [Sher AC](https://profiles.viictr.org/profile/14348256), Zhang H, Mehta B, Thakkar SG, [Grilley B](https://profiles.viictr.org/profile/266987), Wang T, Weiss BD, Montalbano A, Subramaniam M, Xu C, Sachar C, Wells DK, Dotti G, [Metelitsa LS](https://profiles.viictr.org/profile/266187). Author Correction: Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results. Nat Med. 2024 Apr; 30(4):1210. PMID: [38195754](//www.ncbi.nlm.nih.gov/pubmed/38195754).

Citations:  Fields:

Med Medicine (General)Mol Molecular Biology

  7. Espinoza AF, Patel RH, Patel KR, [Badachhape AA](https://profiles.viictr.org/profile/28999111), Whitlock R, [Srivastava RK](https://profiles.viictr.org/profile/30426461), Govindu SR, Duong A, Kona A, Kureti P, Armbruster B, Kats D, Srinivasan RR, Dobrolecki LE, [Yu X](https://profiles.viictr.org/profile/31168798), Najaf Panah MJ, Zorman B, Sarabia SF, Urbicain M, Major A, [Bissig KD](https://profiles.viictr.org/profile/266494), Keller C, Lewis MT, **Heczey A** , [Sumazin P](https://profiles.viictr.org/profile/2560346), L?pez-Terrada DH, [Woodfield SE](https://profiles.viictr.org/profile/15317927), [Vasudevan SA](https://profiles.viictr.org/profile/269879). A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma. J Hepatol. 2024 Apr; 80(4):610-621. PMID: [38242326](//www.ncbi.nlm.nih.gov/pubmed/38242326).

Citations:  Fields:

Gas Gastroenterology

Translation:HumansAnimals

  8. [Arnett AB](https://profiles.viictr.org/profile/34774547), **Heczey A**. GD2-CAR CAR T?cells in patients with osteosarcoma and neuroblastoma-it's not only the T cells that matter. Cancer Cell. 2024 01 08; 42(1):8-10. PMID: [38134937](//www.ncbi.nlm.nih.gov/pubmed/38134937).

Citations:  Fields:

Neo Neoplasms

Translation:HumansCells

  9. Espinoza AF, Patel KR, [Shetty PB](https://profiles.viictr.org/profile/35549192), Whitlock RS, [Sumazin P](https://profiles.viictr.org/profile/2560346), [Yu X](https://profiles.viictr.org/profile/31168798), Sarabia SF, Urbicain M, **Heczey A** , [Masand P](https://profiles.viictr.org/profile/269955), [Woodfield SE](https://profiles.viictr.org/profile/15317927), L?pez-Terrada DH, [Vasudevan SA](https://profiles.viictr.org/profile/269879). Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy. Cancer Med. 2023 12; 12(23):21270-21278. PMID: [37962078](//www.ncbi.nlm.nih.gov/pubmed/37962078); PMCID: [PMC10726870](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10726870).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37962078/citedby/) Fields:

Neo Neoplasms

Translation:Humans

  10. **Heczey A** , [Xu X](https://profiles.viictr.org/profile/12328491), [Courtney AN](https://profiles.viictr.org/profile/9596407), [Tian G](https://profiles.viictr.org/profile/1826488), Barragan GA, Guo L, Amador CM, Ghatwai N, Rathi P, Wood MS, Li Y, Zhang C, Demberg T, Di Pierro EJ, [Sher AC](https://profiles.viictr.org/profile/14348256), Zhang H, Mehta B, Thakkar SG, [Grilley B](https://profiles.viictr.org/profile/266987), Wang T, Weiss BD, Montalbano A, Subramaniam M, Xu C, Sachar C, Wells DK, Dotti G, [Metelitsa LS](https://profiles.viictr.org/profile/266187). Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results. Nat Med. 2023 Jun; 29(6):1379-1388. PMID: [37188782](//www.ncbi.nlm.nih.gov/pubmed/37188782).

Citations:
[17](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/37188782/citedby/) Fields:

Med Medicine (General)Mol Molecular Biology

Translation:HumansAnimalsCellsCTClinical Trials

  11. Whitlock RS, Portuondo JI, Espinoza AF, Ortega R, Galv?n NTN, [Leung DH](https://profiles.viictr.org/profile/268208), [Lopez-Terrada D](https://profiles.viictr.org/profile/266283), [Masand P](https://profiles.viictr.org/profile/269955), Nguyen HN, Patel KA, Goss JA, **Heczey AM** , [Vasudevan SA](https://profiles.viictr.org/profile/269879). Surgical Management and Outcomes of Patients with Multifocal Hepatoblastoma. J Pediatr Surg. 2023 Sep; 58(9):1715-1726. PMID: [37244849](//www.ncbi.nlm.nih.gov/pubmed/37244849).

Citations:  Fields:

Gen General SurgeryPed Pediatrics

Translation:Humans

  12. Patra T, [Cunningham DM](https://profiles.viictr.org/profile/28999202), Meyer K, Toth K, Ray RB, **Heczey A** , Ray R. Targeting Lin28 axis enhances glypican-3-CAR T?cell efficacy against hepatic tumor initiating cell population. Mol Ther. 2023 03 01; 31(3):715-728. PMID: [36609146](//www.ncbi.nlm.nih.gov/pubmed/36609146); PMCID: [PMC10014222](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10014222).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/36609146/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansAnimalsCells

  13. [Steffin DHM](https://profiles.viictr.org/profile/14348352), Muhsen IN, Hill LC, [Ramos CA](https://profiles.viictr.org/profile/267038), [Ahmed N](https://profiles.viictr.org/profile/268944), [Hegde M](https://profiles.viictr.org/profile/270076), Wang T, Wu M, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Whittle SB](https://profiles.viictr.org/profile/3009971), [Lulla PD](https://profiles.viictr.org/profile/3010220), [Mamonkin M](https://profiles.viictr.org/profile/1826306), [Omer B](https://profiles.viictr.org/profile/3009902), [Rouce RH](https://profiles.viictr.org/profile/3010108), **Heczey A** , [Metelitsa LS](https://profiles.viictr.org/profile/266187), [Grilley BJ](https://profiles.viictr.org/profile/266987), Robertson C, Torrano V, [Lapteva N](https://profiles.viictr.org/profile/269143), [Gee AP](https://profiles.viictr.org/profile/268378), [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200), [Heslop HE](https://profiles.viictr.org/profile/269811). Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24. PMID: [35325065](//www.ncbi.nlm.nih.gov/pubmed/35325065); PMCID: [PMC9346960](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9346960).

Citations:  Fields:

Hem Hematology

Translation:HumansCells

  14. Kahla JA, Siegel DA, Dai S, [Lupo PJ](https://profiles.viictr.org/profile/270034), [Foster JH](https://profiles.viictr.org/profile/1826370), [Scheurer ME](https://profiles.viictr.org/profile/265805), **Heczey AA**. Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States. Pediatr Blood Cancer. 2022 10; 69(10):e29763. PMID: [35591805](//www.ncbi.nlm.nih.gov/pubmed/35591805); PMCID: [PMC9658228](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9658228).

Citations:  Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

  15. [Sumazin P](https://profiles.viictr.org/profile/2560346), Peters TL, Sarabia SF, Kim HR, Urbicain M, Hollingsworth EF, Alvarez KR, Perez CR, Najaf Panah MJ, Epps JL, Scorsone K, Zorman B, Katzenstein H, O'Neill AF, Meyers R, Tiao G, Geller J, Ranganathan S, Rangaswami AA, [Woodfield SE](https://profiles.viictr.org/profile/15317927), Goss JA, [Vasudevan SA](https://profiles.viictr.org/profile/269879), **Heczey A** , [Roy A](https://profiles.viictr.org/profile/268647), [Fisher KE](https://profiles.viictr.org/profile/8451894), Patel KR, [Finegold MJ](https://profiles.viictr.org/profile/269596), Pozza A, Alaggio R, L?pez-Terrada DH. Hepatoblastomas with carcinoma features represent a biological spectrum of aggressive neoplasms in children and young adults. J Hepatol. 2022 10; 77(4):1026-1037. PMID: [35577029](//www.ncbi.nlm.nih.gov/pubmed/35577029); PMCID: [PMC9524481](//www.ncbi.nlm.nih.gov/pmc/articles/PMC9524481).

Citations:  Fields:

Gas Gastroenterology

  16. Whitlock RS, Loo C, Patel K, [Bista R](https://profiles.viictr.org/profile/45080771), Goss JA, **Heczey A** , Khan O, [Lopez-Terrada D](https://profiles.viictr.org/profile/266283), [Masand P](https://profiles.viictr.org/profile/269955), Nguyen H, [Mahvash A](https://profiles.viictr.org/profile/12583068), [Vasudevan SA](https://profiles.viictr.org/profile/269879), [Kukreja K](https://profiles.viictr.org/profile/3494043). Transarterial Radioembolization Treatment as a Bridge to Surgical Resection in Pediatric Hepatocellular Carcinoma. J Pediatr Hematol Oncol. 2021 Nov 01; 43(8):e1181-e1185. PMID: [33769387](//www.ncbi.nlm.nih.gov/pubmed/33769387).

Citations:  Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  17. Whitlock RS, Portuondo JI, Commander SJ, Ha TA, Zhu H, Goss JA, [Kukreja KU](https://profiles.viictr.org/profile/3494043), [Leung DH](https://profiles.viictr.org/profile/268208), Terrada DL, [Masand PM](https://profiles.viictr.org/profile/269955), Nguyen HN, [Nuchtern JG](https://profiles.viictr.org/profile/266271), [Wesson DE](https://profiles.viictr.org/profile/267008), **Heczey AA** , [Vasudevan SA](https://profiles.viictr.org/profile/269879). Integration of a dedicated management protocol in the care of pediatric liver cancer: From specialized providers to complication reduction. J Pediatr Surg. 2022 Aug; 57(8):1544-1553. PMID: [34366130](//www.ncbi.nlm.nih.gov/pubmed/34366130).

Citations:  Fields:

Gen General SurgeryPed Pediatrics

Translation:Humans

  18. Goss MB, Munoz FM, [Ruan W](https://profiles.viictr.org/profile/22016564), [O'Mahony CA](https://profiles.viictr.org/profile/267872), [Rana A](https://profiles.viictr.org/profile/5714599), Cotton RT, Moreno NF, **Heczey AA** , [Leung DH](https://profiles.viictr.org/profile/268208), Goss JA, Galv?n NTN. Liver transplant in a recently COVID-19 positive child with hepatoblastoma. Pediatr Transplant. 2021 08; 25(5):e13880. PMID: [32979013](//www.ncbi.nlm.nih.gov/pubmed/32979013); PMCID: [PMC7536987](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7536987).

Citations:
[6](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32979013/citedby/) Fields:

Ped PediatricsTra Transplantation

Translation:Humans

  19. **Heczey A** , [Courtney AN](https://profiles.viictr.org/profile/9596407), Montalbano A, Robinson S, Liu K, Li M, Ghatwai N, Dakhova O, Liu B, Raveh-Sadka T, Chauvin-Fleurence CN, [Xu X](https://profiles.viictr.org/profile/12328491), Ngai H, Di Pierro EJ, Savoldo B, Dotti G, [Metelitsa LS](https://profiles.viictr.org/profile/266187). Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis. Nat Med. 2020 11; 26(11):1686-1690. PMID: [33046868](//www.ncbi.nlm.nih.gov/pubmed/33046868).

Citations:
[57](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/33046868/citedby/) Fields:

Med Medicine (General)Mol Molecular Biology

Translation:HumansCellsCTClinical Trials

  20. [Whittle SB](https://profiles.viictr.org/profile/3009971), [Smith V](https://profiles.viictr.org/profile/270003), Silverstein A, [Parmeter M](https://profiles.viictr.org/profile/269590), [Minard CG](https://profiles.viictr.org/profile/267444), Bernhardt MB, Zage PE, [Venkatramani R](https://profiles.viictr.org/profile/8183321), [Nuchtern JG](https://profiles.viictr.org/profile/266271), **Heczey A** , [Russell HV](https://profiles.viictr.org/profile/267675), Shohet JM, [Foster JH](https://profiles.viictr.org/profile/1826370). Is high-risk neuroblastoma induction chemotherapy possible without G-CSF? A pilot study of safety and treatment delays in the absence of primary prophylactic hematopoietic growth factors. Pediatr Blood Cancer. 2020 10; 67(10):e28417. PMID: [32729196](//www.ncbi.nlm.nih.gov/pubmed/32729196); PMCID: [PMC7722106](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7722106).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32729196/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCTClinical Trials

  21. Tay SY, [Foster J](https://profiles.viictr.org/profile/1826370), **Heczey A** , [Sitton M](https://profiles.viictr.org/profile/3010519). Pediatric Oncology Patients With Vincristine-Induced Recurrent Laryngeal Nerve Palsy: Two Case Reports and a Brief Review of Literature. Ear Nose Throat J. 2021 Dec; 100(10):NP459-NP463. PMID: [32425060](//www.ncbi.nlm.nih.gov/pubmed/32425060).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/32425060/citedby/) Fields:

Oto Otolaryngology

Translation:Humans

  22. Batra SA, Rathi P, Guo L, [Courtney AN](https://profiles.viictr.org/profile/9596407), Fleurence J, Balzeau J, Shaik RS, Nguyen TP, Wu MF, Bulsara S, [Mamonkin M](https://profiles.viictr.org/profile/1826306), [Metelitsa LS](https://profiles.viictr.org/profile/266187), **Heczey A**. Glypican-3-Specific CAR T Cells Coexpressing IL15 and IL21 Have Superior Expansion and Antitumor Activity against Hepatocellular Carcinoma. Cancer Immunol Res. 2020 03; 8(3):309-320. PMID: [31953246](//www.ncbi.nlm.nih.gov/pubmed/31953246); PMCID: [PMC10765595](//www.ncbi.nlm.nih.gov/pmc/articles/PMC10765595).

Citations:
[47](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31953246/citedby/) Fields:

All Allergy and ImmunologyNeo Neoplasms

Translation:HumansAnimalsCells

  23. Luckie TM, Potter SL, [Bacino CA](https://profiles.viictr.org/profile/266588), Shah R, **Heczey A** , [Venkatramani R](https://profiles.viictr.org/profile/8183321). Agenesis of the corpus callosum and hepatoblastoma. Am J Med Genet A. 2020 01; 182(1):224-228. PMID: [31729153](//www.ncbi.nlm.nih.gov/pubmed/31729153).

Citations:  Fields:

Gen Genetics

Translation:Humans

  24. [Xu X](https://profiles.viictr.org/profile/12328491), Huang W, **Heczey A** , Liu D, Guo L, Wood M, Jin J, [Courtney AN](https://profiles.viictr.org/profile/9596407), Liu B, Di Pierro EJ, Hicks J, Barragan GA, Ngai H, Chen Y, Savoldo B, Dotti G, [Metelitsa LS](https://profiles.viictr.org/profile/266187). NKT Cells Coexpressing a GD2-Specific Chimeric Antigen Receptor and IL15 Show Enhanced In Vivo Persistence and Antitumor Activity against Neuroblastoma. Clin Cancer Res. 2019 12 01; 25(23):7126-7138. PMID: [31484667](//www.ncbi.nlm.nih.gov/pubmed/31484667); PMCID: [PMC6891170](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6891170).

Citations:
[44](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31484667/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  25. **Heczey A**. Alliance of the Titans: An Effective Combination of a TKI with CAR T Cells. Mol Ther. 2019 08 07; 27(8):1348-1349. PMID: [31337604](//www.ncbi.nlm.nih.gov/pubmed/31337604); PMCID: [PMC6698246](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6698246).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/31337604/citedby/) Fields:

Mol Molecular BiologyThe Therapeutics

Translation:AnimalsCells

  26. Cowell E, Patel K, **Heczey A** , [Finegold M](https://profiles.viictr.org/profile/269596), [Venkatramani R](https://profiles.viictr.org/profile/8183321), Wu H, Miloh T, L?pez-Terrada D. Predisposing Conditions to Pediatric Hepatocellular Carcinoma and Association With Outcomes: Single-center Experience. J Pediatr Gastroenterol Nutr. 2019 05; 68(5):695-699. PMID: [30676520](//www.ncbi.nlm.nih.gov/pubmed/30676520).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30676520/citedby/) Fields:

Gas GastroenterologyNut Nutritional SciencesPed Pediatrics

Translation:Humans

  27. Haines K, Sarabia SF, Alvarez KR, Tomlinson G, [Vasudevan SA](https://profiles.viictr.org/profile/269879), **Heczey AA** , [Roy A](https://profiles.viictr.org/profile/268647), [Finegold MJ](https://profiles.viictr.org/profile/269596), [Parsons DW](https://profiles.viictr.org/profile/265886), [Plon SE](https://profiles.viictr.org/profile/269771), L?pez-Terrada D. Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation. Pediatr Blood Cancer. 2019 07; 66(7):e27745. PMID: [30977242](//www.ncbi.nlm.nih.gov/pubmed/30977242).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/30977242/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCellsCTClinical Trials

  28. [Rios X](https://profiles.viictr.org/profile/24844972), **Heczey AA**. 50 Years Ago in The Journal of Pediatrics: Survival of Children with Neuroblastoma Treated with Combination Chemotherapy. J Pediatr. 2018 12; 203:233. PMID: [30470379](//www.ncbi.nlm.nih.gov/pubmed/30470379).

Citations:  Fields:

Ped Pediatrics

Translation:Humans

  29. Bavle A, [Grimes A](https://profiles.viictr.org/profile/270042), Zhao S, Zinn D, Jackson A, [Patel B](https://profiles.viictr.org/profile/266137), [Porea T](https://profiles.viictr.org/profile/7968112), [Dutta A](https://profiles.viictr.org/profile/8183291), [Russell H](https://profiles.viictr.org/profile/267675), **Heczey A**. Cost-effectiveness and Improved Parent and Provider Satisfaction With Outpatient Management of Pediatric Oncology Patients, With Low-risk Fever and Neutropenia. J Pediatr Hematol Oncol. 2018 10; 40(7):e415-e420. PMID: [29334532](//www.ncbi.nlm.nih.gov/pubmed/29334532).

Citations:  Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  30. Ng K, [Rana A](https://profiles.viictr.org/profile/5714599), [Masand P](https://profiles.viictr.org/profile/269955), Patel K, **Heczey A** , Goss J, Himes R. Fatal Central Nervous System Post-Transplant Lymphoproliferative Disease in a Patient Who Underwent Liver Transplantation for Hepatoblastoma. J Pediatr Gastroenterol Nutr. 2018 01; 66(1):e21-e23. PMID: [28837514](//www.ncbi.nlm.nih.gov/pubmed/28837514).

Citations:  Fields:

Gas GastroenterologyNut Nutritional SciencesPed Pediatrics

Translation:Humans

  31. Newsome JR, [Venkatramani R](https://profiles.viictr.org/profile/8183321), **Heczey A** , Danysh HE, [Fishman DS](https://profiles.viictr.org/profile/265651), Miloh T. Cholangiocarcinoma Among Children and Adolescents: A Review of the Literature and Surveillance, Epidemiology, and End Results Program Database Analysis. J Pediatr Gastroenterol Nutr. 2018 01; 66(1):e12-e18. PMID: [28937543](//www.ncbi.nlm.nih.gov/pubmed/28937543).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28937543/citedby/) Fields:

Gas GastroenterologyNut Nutritional SciencesPed Pediatrics

Translation:Humans

  32. Punia JN, [Gaikwad A](https://profiles.viictr.org/profile/266018), Hampton OA, **Heczey A** , [Whittle SB](https://profiles.viictr.org/profile/3009971), L?pez-Terrada D. Therapy-related Acute Leukemia With Mixed Phenotype and Novel t(1: 6)(q25;p23) After Treatment for High-risk Neuroblastoma. J Pediatr Hematol Oncol. 2017 11; 39(8):e486-e488. PMID: [28902076](//www.ncbi.nlm.nih.gov/pubmed/28902076).

Citations:  Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:HumansCells

  33. Hamilton EC, Balogh J, [Nguyen DT](https://profiles.viictr.org/profile/40674831), [Graviss EA](https://profiles.viictr.org/profile/267536), **Heczey AA** , [Austin MT](https://profiles.viictr.org/profile/12583172). Liver transplantation for primary hepatic malignancies of childhood: The UNOS experience. J Pediatr Surg. 2017 Oct 12. PMID: [29108844](//www.ncbi.nlm.nih.gov/pubmed/29108844).

Citations:
[3](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29108844/citedby/) Fields:

Gen General SurgeryPed Pediatrics

  34. Szoor A, Vaidya A, Velasquez MP, [Mei Z](https://profiles.viictr.org/profile/267093), Galvan DL, Torres D, [Gee A](https://profiles.viictr.org/profile/268378), **Heczey A** , [Gottschalk S](https://profiles.viictr.org/profile/270181). T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC. Mol Ther Oncolytics. 2017 Sep 15; 6:69-79. PMID: [28856237](//www.ncbi.nlm.nih.gov/pubmed/28856237); PMCID: [PMC5562179](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5562179).

Citations:
[10](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28856237/citedby/)

  35. **Heczey A** , Louis CU, Savoldo B, Dakhova O, Durett A, [Grilley B](https://profiles.viictr.org/profile/266987), Liu H, Wu MF, [Mei Z](https://profiles.viictr.org/profile/267093), [Gee A](https://profiles.viictr.org/profile/268378), Mehta B, Zhang H, [Mahmood N](https://profiles.viictr.org/profile/269285), Tashiro H, [Heslop HE](https://profiles.viictr.org/profile/269811), Dotti G, [Rooney CM](https://profiles.viictr.org/profile/268355), [Brenner MK](https://profiles.viictr.org/profile/268200). CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma. Mol Ther. 2017 09 06; 25(9):2214-2224. PMID: [28602436](//www.ncbi.nlm.nih.gov/pubmed/28602436); PMCID: [PMC5589058](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5589058).

Citations:
[168](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28602436/citedby/)
Fields:

Mol Molecular BiologyThe Therapeutics

Translation:HumansCells

  36. Shi Y, Commander SJ, [Masand PM](https://profiles.viictr.org/profile/269955), **Heczey A** , Goss JA, [Vasudevan SA](https://profiles.viictr.org/profile/269879). Vascular invasion is a prognostic indicator in hepatoblastoma. J Pediatr Surg. 2017 Jun; 52(6):956-961. PMID: [28347528](//www.ncbi.nlm.nih.gov/pubmed/28347528).

Citations:
[7](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28347528/citedby/) Fields:

Gen General SurgeryPed Pediatrics

Translation:Humans

  37. **Heczey A** , Fleurence J, Fougeray S, Bahri M, Cochonneau D, Cl?menceau B, Paris F, Birkl? S. Targeting O-Acetyl-GD2 Ganglioside for Cancer Immunotherapy. J Immunol Res. 2017; 2017:5604891. PMID: [28154831](//www.ncbi.nlm.nih.gov/pubmed/28154831); PMCID: [PMC5244029](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5244029).

Citations:
[12](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/28154831/citedby/) Fields:

All Allergy and Immunology

Translation:HumansAnimalsCells

  38. [Sumazin P](https://profiles.viictr.org/profile/2560346), Chen Y, Sarabia SF, Hampton OA, Patel K, Mistretta TA, Zorman B, Thompson P, **Heczey A** , Comerford S, [Wheeler DA](https://profiles.viictr.org/profile/266937), [Chintagumpala M](https://profiles.viictr.org/profile/268049), Meyers R, Rakheja D, [Finegold MJ](https://profiles.viictr.org/profile/269596), Tomlinson G, [Parsons DW](https://profiles.viictr.org/profile/265886), Trevi?o LR, L?pez-Terrada D. Genomic analysis of hepatoblastoma identifies distinct molecular and prognostic subgroups. Hepatology. 2017 01; 65(1):104-121. PMID: [27775819](//www.ncbi.nlm.nih.gov/pubmed/27775819).

Citations:
[59](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27775819/citedby/) Fields:

Gas Gastroenterology

Translation:Humans

  39. Li W, Guo L, Rathi P, Marinova E, Gao X, Wu MF, Liu H, Dotti G, [Gottschalk S](https://profiles.viictr.org/profile/270181), [Metelitsa LS](https://profiles.viictr.org/profile/266187), **Heczey A**. Redirecting T Cells to Glypican-3 with 4-1BB Zeta Chimeric Antigen Receptors Results in Th1 Polarization and Potent Antitumor Activity. Hum Gene Ther. 2017 05; 28(5):437-448. PMID: [27530312](//www.ncbi.nlm.nih.gov/pubmed/27530312); PMCID: [PMC5444493](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5444493).

Citations:
[33](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27530312/citedby/) Fields:

Gen GeneticsThe Therapeutics

Translation:HumansAnimalsCells

  40. [Tian G](https://profiles.viictr.org/profile/1826488), [Courtney AN](https://profiles.viictr.org/profile/9596407), Jena B, **Heczey A** , Liu D, Marinova E, Guo L, [Xu X](https://profiles.viictr.org/profile/12328491), [Torikai H](https://profiles.viictr.org/profile/17439996), Mo Q, Dotti G, Cooper LJ, [Metelitsa LS](https://profiles.viictr.org/profile/266187). CD62L+ NKT cells have prolonged persistence and antitumor activity in vivo. J Clin Invest. 2016 06 01; 126(6):2341-55. PMID: [27183388](//www.ncbi.nlm.nih.gov/pubmed/27183388); PMCID: [PMC4887157](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4887157).

Citations:
[64](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27183388/citedby/) Fields:

Med Medicine (General)

Translation:HumansAnimalsCells

  41. [Masand PM](https://profiles.viictr.org/profile/269955), Himes RW, Abbas R, Goss JA, [Vasudevan SA](https://profiles.viictr.org/profile/269879), [Finegold MJ](https://profiles.viictr.org/profile/269596), **Heczey A** , Techavichit P. Undifferentiated Embryonal Sarcoma of the Liver (UESL): A Single-Center Experience and Review of the Literature. J Pediatr Hematol Oncol. 2016 05; 38(4):261-8. PMID: [26925712](//www.ncbi.nlm.nih.gov/pubmed/26925712).

Citations:
[23](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26925712/citedby/) Fields:

Hem HematologyNeo NeoplasmsPed Pediatrics

Translation:Humans

  42. **Heczey A** , Louis C. IMAGES IN CLINICAL MEDICINE. Osteopetrosis and Erlenmeyer-Flask Deformity. N Engl J Med. 2015 Sep 03; 373(10):e12. PMID: [26332566](//www.ncbi.nlm.nih.gov/pubmed/26332566); PMCID: [PMC4852467](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4852467).

Citations:
[1](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26332566/citedby/) Fields:

Med Medicine (General)

Translation:Humans

  43. [Austin MT](https://profiles.viictr.org/profile/12583172), Nguyen H, Eberth JM, Chang Y, **Heczey A** , Hughes DP, Lally KP, Elting LS. Health disparities are important determinants of outcome for children with solid tumor malignancies. J Pediatr Surg. 2015 Jan; 50(1):161-6. PMID: [25598116](//www.ncbi.nlm.nih.gov/pubmed/25598116); PMCID: [PMC4408987](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4408987).

Citations:
[13](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25598116/citedby/) Fields:

Gen General SurgeryPed Pediatrics

Translation:Humans

  44. **Heczey A** , Liu D, [Tian G](https://profiles.viictr.org/profile/1826488), [Courtney AN](https://profiles.viictr.org/profile/9596407), Wei J, Marinova E, Gao X, Guo L, Yvon E, Hicks J, [Liu H](https://profiles.viictr.org/profile/265543), Dotti G, [Metelitsa LS](https://profiles.viictr.org/profile/266187). Invariant NKT cells with chimeric antigen receptor provide a novel platform for safe and effective cancer immunotherapy. Blood. 2014 Oct 30; 124(18):2824-33. PMID: [25049283](//www.ncbi.nlm.nih.gov/pubmed/25049283); PMCID: [PMC4215313](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4215313).

Citations:
[113](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25049283/citedby/)
Fields:

Hem Hematology

Translation:HumansAnimalsCells

  45. **Heczey A** , Louis CU. Advances in chimeric antigen receptor immunotherapy for neuroblastoma. Discov Med. 2013 Dec; 16(90):287-94. PMID: [24333408](//www.ncbi.nlm.nih.gov/pubmed/24333408); PMCID: [PMC4106238](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4106238).

Citations:
[18](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24333408/citedby/) Fields:

Med Medicine (General)

Translation:Humans

  46. Song L, Wei J, [Courtney AN](https://profiles.viictr.org/profile/9596407), Gao X, Marinova E, Guo L, **Heczey A** , Asgharzadeh S, Kim E, Dotti G, [Metelitsa LS](https://profiles.viictr.org/profile/266187), Liu D. IL-15 protects NKT cells from inhibition by tumor-associated macrophages and enhances antimetastatic activity. J Clin Invest. 2012 Jun; 122(6):2221-33. PMID: [22565311](//www.ncbi.nlm.nih.gov/pubmed/22565311); PMCID: [PMC3366399](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3366399).

Citations:
[67](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22565311/citedby/) Fields:

Med Medicine (General)

Translation:HumansAnimalsCellsCTClinical Trials

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 46 publications over 13 distinct years, with a maximum of
7 publications in
2024](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|7&cht=bvs&chd=t:0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,14,14,29,14,57,86,57,71,71,29,43,71,100&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2012| 1  
2013| 1  
2014| 2  
2015| 1  
2016| 4  
2017| 6  
2018| 4  
2019| 5  
2020| 5  
2021| 2  
2022| 3  
2023| 5  
2024| 7  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

HECZEY's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (206)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Neuroblastoma](https://profiles.viictr.org/profile/264265)
  * [Hepatoblastoma](https://profiles.viictr.org/profile/247378)
  * [Natural Killer T-Cells](https://profiles.viictr.org/profile/264477)
  * [Liver Neoplasms](https://profiles.viictr.org/profile/263637)
  * [Glypicans](https://profiles.viictr.org/profile/244345)

[Explore](https://profiles.viictr.org/profile/268789/198)

_

Co-Authors (78)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [METELITSA, LEONID](https://profiles.viictr.org/profile/266187)
  * [Arnett, Azlann](https://profiles.viictr.org/profile/34774547)
  * [COURTNEY, AMY](https://profiles.viictr.org/profile/9596407)
  * [STEFFIN, DAVID](https://profiles.viictr.org/profile/14348352)
  * [VASUDEVAN, SANJEEV](https://profiles.viictr.org/profile/269879)

[Explore](https://profiles.viictr.org/profile/268789/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [VAUTHEY, JEAN NICOLAS](https://profiles.viictr.org/profile/12582959)
  * [EL-SERAG, HASHEM](https://profiles.viictr.org/profile/269175)
  * [GOTTSCHALK, STEPHEN](https://profiles.viictr.org/profile/270181)
  * [METELITSA, LEONID](https://profiles.viictr.org/profile/266187)
  * [VASUDEVAN, SANJEEV](https://profiles.viictr.org/profile/269879)

[Explore](https://profiles.viictr.org/profile/268789/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [COURTNEY, AMY](https://profiles.viictr.org/profile/9596407)
  * [METELITSA, LEONID](https://profiles.viictr.org/profile/266187)
  * [RIOS, XAVIER](https://profiles.viictr.org/profile/24844972)
  * [TIAN, GENGWEN](https://profiles.viictr.org/profile/1826488)
  * [XU, XIN](https://profiles.viictr.org/profile/12328491)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

Physical Neighbors
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People whose addresses are nearby this person.

  * [CASTRO, DANNY](https://profiles.viictr.org/profile/265843)
  * [KAHN, RAYMOND](https://profiles.viictr.org/profile/269614)
  * [METELITSA, LEONID](https://profiles.viictr.org/profile/266187)
  * [REDELL, MICHELE](https://profiles.viictr.org/profile/269414)
  * [TIAN, GENGWEN](https://profiles.viictr.org/profile/1826488)

_

